Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.
2.

Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III.

Hara M, Sato M, Takahashi H, Takayama S, Takeyama H.

J Surg Oncol. 2010 Aug 1;102(2):154-7. doi: 10.1002/jso.21599.

PMID:
20648586
3.

Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.

Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.

Ann Surg Oncol. 2008 Dec;15(12):3433-9. doi: 10.1245/s10434-008-0168-8. Epub 2008 Oct 10.

PMID:
18846401
4.

Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year.

Hara M, Sato M, Takahashi H, Takayama S, Takeyama H.

Surg Today. 2011 Oct;41(10):1357-62. doi: 10.1007/s00595-010-4519-2. Epub 2011 Sep 16.

PMID:
21922357
5.

Role of serum carcinoembryonic antigen in the detection of colorectal cancer before and after surgical resection.

Su BB, Shi H, Wan J.

World J Gastroenterol. 2012 May 7;18(17):2121-6. doi: 10.3748/wjg.v18.i17.2121.

6.

Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.

Spratlin JL, Hui D, Hanson J, Butts C, Au HJ.

Clin Colorectal Cancer. 2008 Mar;7(2):118-25. doi: 10.3816/CCC.2008.n.016.

PMID:
18501071
7.
8.
9.

Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.

Park IJ, Choi GS, Lim KH, Kang BM, Jun SH.

Ann Surg Oncol. 2009 Nov;16(11):3087-93. doi: 10.1245/s10434-009-0625-z. Epub 2009 Jul 23.

PMID:
19629600
10.

Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.

Kyoto Y, Momose M, Kondo C, Itabashi M, Kameoka S, Kusakabe K.

Ann Nucl Med. 2010 Jun;24(5):395-401. doi: 10.1007/s12149-010-0372-z. Epub 2010 Apr 3.

PMID:
20364373
11.

The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.

Wichmann MW, Müller C, Lau-Werner U, Strauss T, Lang RA, Hornung HM, Stieber P, Schildberg FW.

Langenbecks Arch Surg. 2000 Jul;385(4):271-5.

PMID:
10958511
12.

Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.

Tsai HL, Chu KS, Huang YH, Su YC, Wu JY, Kuo CH, Chen CW, Wang JY.

J Surg Oncol. 2009 Dec 15;100(8):736-43. doi: 10.1002/jso.21404.

PMID:
19757443
13.

The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.

Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, Has D, Isik G, Asoglu O, Kapran Y, Adalet I.

Ann Nucl Med. 2012 Aug;26(7):551-8. doi: 10.1007/s12149-012-0609-0. Epub 2012 May 30.

PMID:
22644560
14.
15.

Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer.

Ikeda Y, Mori M, Kajiyama K, Kamakura T, Maehara Y, Haraguchi Y, Sugimachi K.

Hepatogastroenterology. 1996 Sep-Oct;43(11):1281-7.

PMID:
8908563
17.

Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.

Gasser M, Gerstlauer C, Grimm M, Bueter M, Lebedeva T, Lutz J, Maeder U, Ribas C, Ribas C, Nichiporuk E, Thalheimer A, Heemann U, Thiede A, Meyer D, Waaga-Gasser AM.

Ann Surg Oncol. 2007 Apr;14(4):1272-84. Epub 2007 Jan 9.

PMID:
17211733
19.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
20.

Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.

Sun LC, Chu KS, Cheng SC, Lu CY, Kuo CH, Hsieh JS, Shih YL, Chang SJ, Wang JY.

BMC Cancer. 2009 Aug 20;9:288. doi: 10.1186/1471-2407-9-288.

Items per page

Supplemental Content

Write to the Help Desk